Citation Impact
Citing Papers
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
2003 Standout
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Inorganic Nanoparticles in Cancer Therapy
2010
Liver fibrosis – from bench to bedside
2003 Standout
Hereditary Hemorrhagic Telangiectasia
1995 Standout
Clinical classification of pulmonary hypertension
2004 Standout
Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era
2015 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
2001
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Biological properties of “naked” metal nanoparticles☆
2008
Pathologic Assessment of Non-alcoholic Fatty Liver Disease
2007
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Intracranial Hemorrhage in Infants and Children With Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome)
2002
Nonalcoholic Steatohepatitis
1980 Standout
Nonalcoholic Fatty Liver Disease
2001 Standout
Shock and Tissue Injury Induced by Recombinant Human Cachectin
1986 StandoutScienceNobel
Do prostacyclin and thromboxane play a role in endotoxic shock?
1981
Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids.
1977
The pulmonary ultrastructure in septic shock
1970
MASSIVE THROMBOSIS PRODUCED BY FATTY ACID INFUSION*
1963
The role of endotoxin in protection of adult rats from oxygen-induced lung toxicity.
1978 StandoutNobel
Studying Neural Organization in Aplysia with the Scanning Electron Microscope
1969 Science
Familial pulmonary hypertension and multiple abnormalities of large systemic arteries in Osler's disease
1972
Neurological manifestations of hereditary hemorrhagic telangiectasia (rendu‐osler‐weber disease): Report of 2 cases and review of the literature
1978
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus
1980
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells
1986 StandoutNobel
The vascular endothelium-pathobiologic significance.
1978
Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.
1982 Standout
Pulmonary Vasodilator Responses to Nitroprusside and Nitroglycerin in the Dog
1981 StandoutNobel
Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
1979
Endotoxin and prevention of hypoxic pulmonary vasoconstriction.
1976
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
An Analysis of Dishabituation and Sensitization of The Gill-Withdrawal Reflex In Aplysia
1971 StandoutNobel
Works of William E. Jaques being referenced
Vascular Lesion of Hereditary Hemorrhagic Telangiectasia
1959
PULMONARY VASCULAR RESPONSES TO ADENOSINE DIPHOSPHATE
1971
Ultrastructure of the alveolar-capillary membrane in congenital and acquired heart disease.
1967
Application of the scanning electron microscope to human tissues
1965
Pulmonary vascular response to endotoxin in intact dogs.
1973
The Incidence of Portal Cirrhosis and Fatty Metamorphosis in Patients Dying with Diabetes Mellitus
1953
Pulmonary Embolization in the Dog: Its Effects on Blood Coagulation and on Pulmonary Artery Pressures
1961
EXPERIENCES WITH THE USE OF RADIOACTIVE COLLOIDAL GOLD IN THE TREATMENT OF CANCER*
1955